IMPACT OF UK-INDIA FREE TRADE AGREEMENT (FTA) ON CANCER CARE IN INDIA - Dr Raj Nagarkar, HCG Manavata Cancer Centre

▴ CANCER CARE IN INDIA
“With the recent UK-India Free Trade Agreement (FTA) reducing import tariffs on advanced medical equipment, we indeed foresee significant positive implications for healthcare providers like HCG Manavata Cancer Centre.

Nashik, May 12: “With the recent UK-India Free Trade Agreement (FTA) reducing import tariffs on advanced medical equipment, we indeed foresee significant positive implications for healthcare providers like HCG Manavata Cancer Centre.

The lowered import costs on high-end medical technologies — including robotic surgical systems and precision oncology equipment — have the potential to directly benefit both providers and patients. At HCG Manavata, we are committed to delivering cutting-edge cancer care, and reduced capital costs for advanced surgical technologies will allow us to enhance access to sophisticated procedures such as robotic-assisted surgeries.

Over time, as these technologies become more accessible and costs decline, we anticipate a narrowing gap between the pricing of robotic-assisted surgeries and conventional cancer surgeries. This will make advanced cancer treatments more affordable and accessible to a broader segment of patients, particularly in tier-II and tier-III cities, where affordability has historically been a barrier.

Moreover, this development is poised to elevate the standard of cancer care in India. Greater availability of advanced equipment will enable more precise, minimally invasive surgeries with shorter recovery times and better outcomes — aligning Indian cancer care more closely with global best practices.

We view this as an opportunity not just to upgrade technology but also to expand equitable access to high-quality cancer care, furthering our mission of bringing comprehensive oncology services to every patient in need,” says Prof Dr Raj Nagarkar, Chief of Surgical Oncology & Robotic Services & Managing Director, HCG Manavata Cancer Centre (HCGMCC) & Hospitals.

 

About HCG Manavata Cancer Centre (HCGMCC): -

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India's first NABH-accredited facility. With over 50 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 65,000 surgeries, including 1,100 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026